Brandon R. Rosen

2.8k citations

20 papers · 2.3k indexed · 3 hit papers · h-index 10

Organic Chemistry top 1%
- Catalytic C–H Functionalization Methods 7
- Synthetic Organic Chemistry Methods 5
- Click Chemistry and Applications 4
- Catalytic Cross-Coupling Reactions 2
Electrochemistry top 5%
Renewable Energy, Sustainability and the Environment top 5%
Inorganic Chemistry top 5%
Pharmaceutical Science top 5%
Physiology
- Adenosine and Purinergic Signaling 9
Biomedical Engineering
- Nanoplatforms for cancer theranostics 5
Oncology
- Peptidase Inhibition and Analysis 3
- Cancer Immunotherapy and Biomarkers 3

Co-authors: Phil S. BaranYong ChenKe Chen Martin D. Eastgate Jiaze Tang Alexander G. O’Brien Erik W. Werner John P. Wolfe
Cited by: Organic Chemistry Electrochemistry Renewable Energy, Sustainability and the Environment
Journals: Nature (1 paper)Journal of the American Chemical Society (1 paper)Angewandte Chemie International Edition (1 paper)
Partner nations: United States China Germany

In The Last Decade

Brandon R. Rosen

18 papers receiving 2.3k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Brandon R. Rosen

Since Specialization

Citations

This map shows the geographic impact of Brandon R. Rosen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brandon R. Rosen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brandon R. Rosen more than expected).

Fields of papers citing papers by Brandon R. Rosen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brandon R. Rosen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brandon R. Rosen. The network helps show where Brandon R. Rosen may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Brandon R. Rosen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Brandon R. Rosen Line = papers co-authored together Brandon R. Rosen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Development of a Scalable Synthesis of Casdatifan (AB521), a Potent, Selective, Clinical-Stage Inhibitor of HIF-2α Organic Process Research & Development ·Clayton Hardman,Artur K. Mailyan,Guillaume Mata,Joel W. Beatty,Samuel L. Drew,Jeremy Fournier,Jarosław Kalisiak,Brandon R. Rosen,Matthew Epplin,Balint Gal,Kai Yu,Zhang Wang,Karl T. Haelsig,Anh Tran,Manmohan R. Leleti,Jay P. Powers,Kenneth V. Lawson	2025	1
2	Abstract PR001: Discovery of Etrumadenant, a first-in-class dual A2a and A2b adenosine receptor antagonist for cancer immunotherapy Molecular Cancer Therapeutics ·Ehesan U. Sharif,Dillon H. Miles,Brandon R. Rosen,Joel W. Beatty,Jenna L. Jeffrey,Laurent Debien,Rhiannon Thomas‐Tran,Debashis Mandal,Daniel DiRenzo,Sachie Marubayashi,Kristen Zhang,Ferdie Soriano,Elaine Ginn,Divyank Soni,Pei‐Yu Chen,Lixia Jin,Steve W. Young,Matt Walters,Manmohan R. Leleti,Jay P. Powers	2024	0
3	Discovery of Potent and Selective Methylenephosphonic Acid CD73 Inhibitors Journal of Medicinal Chemistry ·Ehesan U. Sharif,Jarosław Kalisiak,Kenneth V. Lawson,Dillon H. Miles,Eric T. Newcomb,Erick A. Lindsey,Brandon R. Rosen,Laurent Debien,Ada Chen,Xiaoning Zhao,Stephen W. Young,Nigel P.C. Walker,Norbert Sträter,Emma Rose Scaletti,Lixia Jin,Guifen Xu,Manmohan R. Leleti,Jay P. Powers	2021	26
4	Abstract 6649: Inhibiting adenosine signaling and KRAS enhances the effect of α-PD-1 therapy in a KRASG12C/TP53R172H/+ pancreatic cancer model Cancer Research ·Thuc Le,Evan R. Abt,Woosuk Kim,Akshata R. Udyavar,Arthur Cho,Joe Capri,Jing Cui,Razmik Ghukasyan,Luyi Li,Daniel DiRenzo,Brandon R. Rosen,Timothy R. Donahue,Matt Walters,Caius G. Radu	2020	1
5	Abstract A46: CD73 inhibition enhances the effect of anti-PD-1 therapy on KRAS-mutated pancreatic cancer model Cancer Immunology Research ·Thuc Le,Akshata R. Udyavar,Woosuk Kim,Arthur E. Cho,Luyi Li,Daniel DiRenzo,Brandon R. Rosen,Matthew J. Walters,Joanne B.L. Tan,Caius G. Radu	2020	2
6	Development of a Scalable and Practical Synthesis of AB928, a Dual A_2a/A_2b Receptor Antagonist Organic Process Research & Development ·Ehesan U. Sharif,Dillon H. Miles,Brandon R. Rosen,Jenna L. Jeffrey,Laurent Debien,Jay P. Powers,Manmohan R. Leleti	2020	3
7	Improved synthesis of sterically encumbered heteroaromatic biaryls from aromatic β-keto esters Tetrahedron Letters ·Brandon R. Rosen,Ehesan U. Sharif,Dillon H. Miles,Nicholas S. Chan,Manmohan R. Leleti,Jay P. Powers	2020	4
8	Abstract A162: AB928, a dual antagonist of the A2aR and A2bR adenosine receptors, relieves adenosine-mediated immune suppression Cancer Immunology Research ·Daniel DiRenzo,Dana Piovesan,Joanne B.L. Tan,Dillon H. Miles,Manmohan R. Leleti,Timothy Park,Ferdie Soriano,Bryan Handlos,Jenna L. Jeffrey,Ehesan U. Sharif,Brandon R. Rosen,Ulrike Schindler,Jay P. Powers,Matthew J. Walters	2019	7
9	Final results of the phase I study in healthy volunteers of AB928, a dual antagonist of the A2aR and A2bR adenosine receptors being studied as an activator of anti-tumor immune response Annals of Oncology ·Lisa Seitz,D. Ashok,Manmohan R. Leleti,Jay P. Powers,Brandon R. Rosen,Dillon H. Miles,Ehesan U. Sharif,Lin Jin,A. Park,S. R. Young,Aimee Rieger,Uli Schindler,Joyson Karakunnel,Matt Walters	2018	2
10	AB928, a dual antagonist of the A 2a R and A 2b R adenosine receptors, leads to greater immune activation and reduced tumor growth when combined with chemotherapy European Journal of Cancer ·Ulrike Schindler,Lisa Seitz,D. Ashok,Dana Piovesan,Joanne B.L. Tan,Daniel DiRenzo,F Yin,Manmohan R. Leleti,Brandon R. Rosen,Dillon H. Miles,Lixia Jin,T. Park,S. R. Young,Ferdie Soriano,Aimee Rieger,Joyson Karakunnel,Ehesan U. Sharif,Jesse R. Powers,Matt Walters	2018	5
11	Abstract 4572: Characterization of the potent and selective A2aR antagonist AB928 for the treatment of cancer Cancer Research ·Matt Walters,Joanne B.L. Tan,Annette Becker,Fangfang Yi,Tim Park,Manmohan R. Leleti,Brandon R. Rosen,Ehesan U. Sharif,Laurent Debien,Steve Young,Wan Hsin Lim,Stefan Garrido-Shaqfeh,Juan C. Jaén,Jay P. Powers	2017	9
12	Scalable and sustainable electrochemical allylic C–H oxidationbreakdown → Nature ·Evan J. Horn,Brandon R. Rosen,Yong Chen,Jiaze Tang,Ke Chen,Martin D. Eastgate,Phil S. Baran	2016	636
13	Synthetic Organic Electrochemistry: An Enabling and Innately Sustainable Methodbreakdown → ACS Central Science ·Evan J. Horn,Brandon R. Rosen,Phil S. Baran	2016	886
14	Total Synthesis of Dixiamycin B by Electrochemical Oxidationbreakdown → Journal of the American Chemical Society ·Brandon R. Rosen,Erik W. Werner,Alexander G. O’Brien,Phil S. Baran	2014	321
15	CH Functionalization Logic Enables Synthesis of (+)‐Hongoquercin A and Related Compounds Angewandte Chemie International Edition ·Brandon R. Rosen,Leah R. Simke,Peter Thuy-Boun,Darryl D. Dixon,Jin‐Quan Yu,Phil S. Baran	2013	157
16	CH Functionalization Logic Enables Synthesis of (+)‐Hongoquercin A and Related Compounds Angewandte Chemie ·Brandon R. Rosen,Leah R. Simke,Peter Thuy-Boun,Darryl D. Dixon,Jin‐Quan Yu,Phil S. Baran	2013	50
17	Enantioconvergent Synthesis of (+)-Aphanorphine via Asymmetric Pd-Catalyzed Alkene Carboamination Organic Letters ·Duy Ngoc,Brandon R. Rosen,John P. Wolfe	2011	28
18	Mild Pd-Catalyzed N-Arylation of Methanesulfonamide and Related Nucleophiles: Avoiding Potentially Genotoxic Reagents and Byproducts Organic Letters ·Brandon R. Rosen,J. Craig Ruble,Thomas J. Beauchamp,Antonio Navarro	2011	98
19	Use of Aryl Chlorides as Electrophiles in Pd-Catalyzed Alkene Difunctionalization Reactions The Journal of Organic Chemistry ·Brandon R. Rosen,Joshua E. Ney,John P. Wolfe	2010	29
20	New Strategy for the Synthesis of Substituted Morpholines The Journal of Organic Chemistry ·Matthew L. Leathen,Brandon R. Rosen,John P. Wolfe	2009	72

About Brandon R. Rosen

Brandon R. Rosen is a scholar working on Physiology, Organic Chemistry and Pharmacology, having authored 20 papers that have together received 2.3k indexed citations. Recurring topics across this work include Adenosine and Purinergic Signaling (9 papers), Catalytic C–H Functionalization Methods (7 papers), Nanoplatforms for cancer theranostics (5 papers), Synthetic Organic Chemistry Methods (5 papers), Click Chemistry and Applications (4 papers), Peptidase Inhibition and Analysis (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Catalytic Cross-Coupling Reactions (2 papers). The work is most often cited by research in Organic Chemistry (2.0k citations), Electrochemistry (178 citations) and Renewable Energy, Sustainability and the Environment (384 citations). Brandon R. Rosen has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Phil S. Baran, Yong Chen, Ke Chen, Martin D. Eastgate, Jiaze Tang, Alexander G. O’Brien, Erik W. Werner, John P. Wolfe, Darryl D. Dixon and Jin‐Quan Yu. Their work appears in journals such as Nature, Journal of the American Chemical Society and Angewandte Chemie International Edition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact